肺外结核

Ong A, Creasman J, Hopewell PC, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis. 2004;38:25-31.

• 摘要

Iseman MD. A clinician's guide to tuberculosis. Baltimore: Lippincott, Williams & Wilkins, 1999.

Mazurek M, Jereb J, Vernon A, et al.; IGRA Expert Committee, Centers for Disease Control and Prevention. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR. 2010;59:1-25.

• 全文
• 摘要

Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360:52-34.

• 摘要

1.  Polesky A, Grove W, Bhatia G. Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome. Medicine (Baltimore). 2005;84:350-362.

• 摘要

2.  Baumann MH, Nolan R, Petrini M, et al. Pleural tuberculosis in the United States: incidence and drug resistance. Chest. 2007;131:1125-1132.

• 摘要

3.  Ong A, Creasman J, Hopewell PC, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis. 2004;38:25-31.

• 摘要

4.  Hawn TR, Dunstan SJ, Thwaites GE, et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis. 2006;194:1127-1134.

• 摘要

5.  Thwaites G, Chau TT, Mai NT, et al. Tuberculous meningitis. J Neurol Neurosurg Psych. 2000;68:289-299.

• 摘要

6.  World Health Organization. Global tuberculosis report. 2014. http://www.who.int (last accessed 16 December 2016).

• 全文

7.  World Health Organization. Tuberculosis fact sheet. October 2015. http://www.who.int/mediacentre/factsheets/fs104/en/ (last accessed 16 December 2016).

• 全文

8.  Public Health England. Tuberculosis in the UK: 2014 report. London: Public Health England; 2014.

• 全文

9.  Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2013. September 2014. http://www.cdc.gov/tb/ (last accessed 16 December 2016).

• 全文

10.  Peto HM, Pratt RH, Harrington TA, et al. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009;49:1350-1357.

• 全文
• 摘要

11.  Gonzalez OY, Adams G, Teeter LD, et al. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178-1185.

• 摘要

12.  Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38:199-205.

• 摘要

13.  Dye C. Global epidemiology of tuberculosis. Lancet. 2006;367:938-940.

• 摘要

14.  Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004:350:2060-2067.

• 摘要

15.  Chow KM, Chow VC, Hung LC, et al. Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples. Clin Infect Dis. 2002;35:409-413.

• 摘要

16.  Iseman MD. A clinician's guide to tuberculosis. Baltimore: Lippincott, Williams & Wilkins, 1999.

17.  Colditz GA, Brewer TF, Berkley CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA. 1994;271:698-702.

• 摘要

18.  Musellim B, Erturan S, Sonmez Duman E, et al. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9:1220-1223.

• 摘要

19.  Marks SM, Taylor Z, Qualls NL, et al. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000;162:2033-2038.

• 全文
• 摘要

20.  American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221-S247.

• 全文
• 摘要

21.  Zuber PL, McKenna MT, Binkin NJ, et al. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA. 1997;278:304-307.

• 摘要

22.  Gonzalez OY, Teeter LD, Thanh BT, et al. Extrathoracic tuberculosis lymphadenitis in adult HIV seronegative patients: a population-based analysis in Houston, Texas, USA. Int J Tuber Lung Dis. 2003;7:987-993.

• 摘要

23.  Markowitz N, Hansen NI, Hopewell PC, et al. Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med. 1997;126:123-132.

• 摘要

24.  Daley CL, Small PM, Schechter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency syndrome. N Engl J Med. 1992;326:231.

• 摘要

25.  Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-550.

• 摘要

26.  Winthrop KL. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol. 2006;2:602-610.

• 摘要

27.  Jick SS, Lieberman ES, Rahman MU, et al. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006;55:19-26.

• 摘要

28.  Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38:1261-1265.

• 摘要

29.  Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42:1592-1595.

• 摘要

30.  International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60:555-564.

• 摘要

31.  Rieder HL, Snider DE Jr, Cauthen GM, et al. Extrapulmonary tuberculosis in the United States. Am Rev Resp Dis. 1990;141:347-351.

• 摘要

32.  Cantwell MF, McKenna MT, McCray E, et al. Tuberculosis and race/ethnicity in the United States, impact of socioeconomic status. Am J Respir Crit Care Med. 1998;157:1016-1020.

• 全文
• 摘要

33.  Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:e1-e33.

• 全文
• 摘要

34.  Parimon T, Spitters CE, Muangman N, et al. Unexpected pulmonary involvement in extrapulmonary tuberculosis patients. Chest. 2008;134:589-594.

• 全文
• 摘要

35.  Mazurek M, Jereb J, Vernon A, et al.; IGRA Expert Committee, Centers for Disease Control and Prevention. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR. 2010;59:1-25.

• 全文
• 摘要

36.  World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF System. 2011. http://www.who.int/en (last accessed 16 December 2016).

• 全文

37.  Denkinger CM, Schumacher SG, Boehme CC, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44:435-446.

• 摘要

38.  Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147-e195.

• 全文
• 摘要

39.  Hooper C, Lee YC, Maskell N; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults. Thorax. 2010;65(Suppl 2):ii4-ii17.

• 全文
• 摘要

40.  Kim HJ, Lee Hj, Kwon SY, et al. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest. 2006;129:1253-1258.

• 摘要

41.  Siebert AF, Haynes J JR, Middleton R, et al. Tuberculous pleural effusion: twenty-year experience. Chest. 1991;99:883-886.

• 摘要

42.  Mariconda M,Cozzolino A, Attingenti P, et al. Osteoarticular tuberculosis in a developed country. J Infect. 2007;54:375-380.

• 摘要

43.  Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59:167-187.

• 摘要

44.  Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol. 2004;42:378-379.

• 摘要

45.  Riquelme A, Calvo M, Salech F, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculosis peritonitis: a meta-analysis. J Clin Gastroenterol. 2006;40:705-710.

• 摘要

46.  Elder N. Extrapulmonary tuberculosis. Arch Fam Med. 1992;1:91-98.

• 摘要

47.  Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis. 1990;12:583-590.

• 摘要

48.  Crump JA, Reller LB. Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture. Clin Infect Dis. 2003;37:1037-1043.

• 摘要

49.  Maartens G, Willcox, Benatar SR, et al. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities and outcome in 109 treated adults. Am J Med. 1990;89;291-296.

• 摘要

50.  Geldmacher H, Taube C, Kroeger C, et al. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002;121:1177-1182.

• 摘要

51.  Shriner KA, Mathisen GE, Goetz MB. Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis. 1992;15:601-605.

• 摘要

52.  Gopi A, Madhaven SM, Sharma SK, et al. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131:880-889.

• 摘要

53.  Weir MR, Thorton GF. Extrapulmonary tuberculosis: experience of a community hospital and review of the literature. Am J Med. 1985;79:467-478.

• 摘要

54.  Baydur A. The spectrum of extrapulmonary tuberculosis. West J Med. 1977;126:253-262.

• 摘要

55.  Powell DA. Tuberculous lymphadenitis and parotitis. In: Schlossberg D, ed. Tuberculosis and nontuberculous mycobacterial infections, 5th ed. Berkshire, UK: 2006.

56.  Jha BC, Dass A, Nagarkar NM, et al. Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J. 2001;77:185-187.

• 摘要

57.  Nataraj G, Kurup S, Pandit A, et al. Correlation of fine needle aspiration cytology, smear and culture in tuberculous lymphadenitis: a prospective study. J Postgrad Med. 2002;48:113-116.

• 摘要

58.  Singh KK, Muralidhar M, Kumar A, et al. Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J Clin Pathol. 2000;53:355-361.

• 摘要

59.  Field S, Lewis S. Intestinal and peritoneal tuberculosis. In: Rom WN, Garay S, eds. Tuberculosis, 2nd ed. Philadelphia: Lippincott, Williams and Wilkins; 2003.

60.  Kirsch CM, Kroe DM, Azzi RL, et al. The optimal number of pleural biopsy specimens for a diagnosis of tuberculous pleurisy. Chest. 1997;112:702-706.

• 摘要

61.  Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2003;3:633-643.

• 摘要

62.  Pai M, Flores LL, Hubbard A, et al. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infec Dis. 2004;23:6.

• 全文
• 摘要

63.  Willcox PA, Potgieter PD, Bateman ED, et al. Rapid diagnosis of sputum negative miliary tuberculosis using the flexible fibreoptic bronchoscope. Thorax. 1986;41:681-684.

• 摘要

64.  Pai M, Menzies D. Interferon-release assays: what is their role in the diagnosis of active tuberculosis. Clin Infect Dis. 2007;44:74-77.

• 摘要

65.  Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis. 2007;44:69-73.

• 摘要

66.  Lai KK, Stottmeier KD, Sherman IH, et al. Mycobacterial cervical lymphadenopathy: relationship of etiologic agents to age. JAMA. 1984;251:1286-1288.

• 摘要

67.  Xu HB, Jiang RH, Li L, et al. Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis. 2010;14:1382-1387.

• 摘要

68.  US Preventive Services Task Force. Final recommendation statement latent tuberculosis infection: screening. September 2016. https://www.uspreventiveservicestaskforce.org/ (last accessed 15 December 2016).

• 全文

69.  World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. 2013. http://www.who.int/ (last accessed 8 May 2017).

• 全文

70.  World Health Organisation. WHO treatment guidelines for drug-resistant tuberculosis. 2016. http://www.who.int (last accessed 15 December 2016).

• 全文

71.  Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60:1650-1653.

• 全文
• 摘要

72.  World Health Organization. Guidelines on the management of latent tuberculosis infection. 2015. http://www.who.int/ (last accessed 15 December 2016).

• 全文

73.  National Institute for Health and Care Excellence. Tuberculosis. May 2016. https://www.nice.org.uk/ (last accessed 15 December 2016).

• 全文

74.  Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155-2166.

• 全文
• 摘要

75.  Villarino ME, Scott NA, Weis SE, et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015;169:247-255.

• 摘要

76.  Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;(4):CD002244.

• 全文
• 摘要

77.  Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;371:1121-1130.

• 全文
• 摘要

78.  Panel on Antiretroviral Guidelines for Adults and Adolescents; Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. July 2016. http://www.aidsinfo.nih.gov (last accessed 16 December 2016).

• 全文

79.  British HIV Association. Guidelines for the treatment of TB/HIV co-infection. 2011. http://www.bhiva.org (last accessed 16 December 2016).

• 全文

80.  Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. November 2015. https://aidsinfo.nih.gov (last accessed 16 December 2016).

• 全文

81.  Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-1751.

• 摘要

82.  Centers for Disease Control and Prevention. Managing drug interactions in the treatment of HIV-related tuberculosis. June 2013. http://www.cdc.gov (last accessed 16 December 2016).

• 全文

83.  Lee M, Lee J, Carroll MW, et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med. 2012;367:1508-1518.

• 全文
• 摘要

84.  Fortún J, Martín-Dávila P, Navas E, et al. Linezolid for the treatment of multidrug-resistant tuberculosis. J Antimicrob Chemother. 2005;56:180-185.

• 摘要

85.  Sood R, Rao M, Singhal S, et al. Activity of RBx 7644 and RBx 8700, new investigational oxaxolidinones, against Mycobacterium tuberculosis infected urine macrophages. Int J Antimicrob Agents. 2005;25:464-468.

• 摘要

86.  Diacon AH, Pym A, Grobusch M, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med. 2009;360:2397-2405.

• 全文
• 摘要

87.  Centers for Disease Control and Prevention. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. MMWR Recomm Rep. 2013;62:1-12 (erratum in: MMWR Recomm Rep. 2013;62:906).

• 全文
• 摘要

88.  Anyama N, Bracebridge S, Black C, et al. What happens to people diagnosed with tuberculosis? A population-based cohort. Epidemiol Infect. 2007;135:1069-1076.

• 摘要

89.  Fielder JF, Chaulk CP, Dalvi M, et al. A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates. Int J Tuberc Lung Dis. 2002;6:1114-1117.

• 摘要

90.  Straetemans M, Glaziou P, Bierrenbach AL, et al. Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS One. 2011;6:e20755.

• 全文
• 摘要

91.  Long R, O'Connor R, Palayew M, et al. Disseminated tuberculosis with and without a miliary pattern on chest radiograph: a clinical-pathologic-radiologic correlation. Int J Tuberc Lung Dis. 1997;1:52-58.

• 摘要

92.  Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis. 2005;40:1368-1371.

• 摘要

93.  Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N EnglJ Med. 2010;363:257-265.

• 全文
• 摘要

94.  Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362:697-706.

• 全文
• 摘要

95.  Narita M, Ashkin D, Hollender ES, et al. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158:157-161.

• 全文
• 摘要

96.  Cheng V, Ho P, Lee R, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:803-809.

• 摘要

97.  Manosuthi W, Kiertiburanakul S, Phoorisri T, et al. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect. 2006;53:357-363.

• 摘要

98.  Ahuja SS, Ahuja SK, Phelps KR, et al. Hemodynamic confirmation of septic shock in disseminated tuberculosis. Crit Care Med. 1992;20:901-903.

• 摘要

99.  Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360:52-34.

• 摘要

100.  van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999;341:1174-1179.

• 摘要